Loading...
Aspira Women's Health Inc.
AWH•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.08
$0.00(0.00%)
Aspira Women's Health Inc. (AWH) Financial Performance & Income Statement Overview
Review Aspira Women's Health Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.31%
↑ 0.31%
Operating Income Growth
13.65%
↑ 13.65%
Net Income Growth
21.55%
↑ 21.55%
Operating Cash Flow Growth
23.79%
↑ 23.79%
Operating Margin
-159.09%
↓ 159.09%
Gross Margin
62.58%
↑ 62.58%
Net Profit Margin
-110.85%
↓ 110.85%
ROE
466.24%
↑ 466.24%
ROIC
-506.26%
↓ 506.26%
Aspira Women's Health Inc. (AWH) Income Statement & Financial Overview
Review Aspira Women's Health Inc.'s (AWH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.35M | $2.26M | $2.42M | $2.15M |
| Cost of Revenue | $860000.00 | $902000.00 | $1.002M | $939000.00 |
| Gross Profit | $1.49M | $1.35M | $1.42M | $1.21M |
| Gross Profit Ratio | $0.63 | $0.60 | $0.59 | $0.56 |
| R&D Expenses | $500000.00 | $908000.00 | $952000.00 | $906000.00 |
| SG&A Expenses | $4.42M | $4.19M | $4.86M | $5.02M |
| Operating Expenses | $4.92M | $5.10M | $5.81M | $5.92M |
| Total Costs & Expenses | $5.78M | $6.001M | $6.82M | $6.86M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $5000.00 | $10000.00 | $5000.00 |
| Depreciation & Amortization | $14000.00 | $23000.00 | $26000.00 | $29000.00 |
| EBITDA | -$4.58M | -$3.74M | -$4.37M | -$4.68M |
| EBITDA Ratio | -$1.95 | -$1.66 | -$1.80 | -$2.17 |
| Operating Income | -$3.43M | -$3.74M | -$4.39M | -$4.71M |
| Operating Income Ratio | -$1.46 | -$1.66 | -$1.81 | -$2.19 |
| Other Income/Expenses (Net) | $2.04M | $197000.00 | $863000.00 | $81000.00 |
| Income Before Tax | -$1.39M | -$3.55M | -$3.53M | -$4.63M |
| Income Before Tax Ratio | -$0.59 | -$1.57 | -$1.46 | -$2.15 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$14276.00 |
| Net Income | -$1.39M | -$3.55M | -$3.53M | -$4.63M |
| Net Income Ratio | -$0.59 | -$1.57 | -$1.46 | -$2.15 |
| EPS | -$0.10 | -$0.23 | -$0.28 | -$0.39 |
| Diluted EPS | -$0.10 | -$0.23 | -$0.28 | -$0.39 |
| Weighted Avg Shares Outstanding | $14.13M | $15.41M | $12.52M | $11.85M |
| Weighted Avg Shares Outstanding (Diluted) | $14.13M | $15.41M | $12.52M | $11.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan